Cardiac resynchronization therapy contraindications: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
(/* American College of Cardiology Foundation/American Heart Association Task Force/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities {{cite web |url=http://content.onlinejacc.org/article.aspx?articl...) |
||
| Line 12: | Line 12: | ||
==American College of Cardiology Foundation/American Heart Association Task Force/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities <ref name="urlAmerican College of Cardiology Foundation | Journal of the American College of Cardiology | 2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm AbnormalitiesA Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines">{{cite web |url=http://content.onlinejacc.org/article.aspx?articleid=1357576 |title=American College of Cardiology Foundation | Journal of the American College of Cardiology | 2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm AbnormalitiesA Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines |format= |work= |accessdate=2012-09-11}}</ref> (DO NOT EDIT)== | ==American College of Cardiology Foundation/American Heart Association Task Force/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities <ref name="urlAmerican College of Cardiology Foundation | Journal of the American College of Cardiology | 2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm AbnormalitiesA Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines">{{cite web |url=http://content.onlinejacc.org/article.aspx?articleid=1357576 |title=American College of Cardiology Foundation | Journal of the American College of Cardiology | 2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm AbnormalitiesA Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines |format= |work= |accessdate=2012-09-11}}</ref> (DO NOT EDIT)== | ||
{ | {|class="wikitable" | ||
|- | |||
== | |colspan="1" style="text-align:center; background:LightCoral"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class III]] (Harm) | ||
|- | |||
'''1 | |bgcolor="LightCoral"|<nowiki>"</nowiki>'''1.''' CRT is not recommended for patients with NYHA class I or II symptoms and non-LBBB pattern with QRS duration less than 150 ms. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])'' <nowiki>"</nowiki> | ||
|- | |||
'''2 | |bgcolor="LightCoral"|<nowiki>"</nowiki>'''2.''' CRT is not indicated for patients whose comorbidities and/or frailty limit survival with good functional capacity to less than 1 year. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])'' <nowiki>"</nowiki> | ||
|} | |||
==References== | ==References== | ||
Revision as of 15:08, 5 October 2012
|
Cardiac resynchronization therapy Microchapters |
|
Treatment |
|---|
|
Cardiac resynchronization therapy contraindications On the Web |
|
American Roentgen Ray Society Images of Cardiac resynchronization therapy contraindications |
|
Cardiac resynchronization therapy contraindications in the news |
|
Blogs on Cardiac resynchronization therapy contraindications |
|
Directions to Hospitals Administering Cardiac resynchronization therapy |
|
Risk calculators and risk factors for Cardiac resynchronization therapy contraindications |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief:: Bhaskar Purushottam, M.D. [2]
Synonyms and Keywords: CRT
Overview
CRT is contraindicated in patients who are symptomatic or who have a limited life expectancy.
Contraindications
- Patients who are asymptomatic with a reduced LVEF who have no other indications for pacing.
- Patients who have a limited life expectancy due to a non-cardiac condition.
- Patients who have a limited functional capacity due to a chronic non-cardiac condition.
American College of Cardiology Foundation/American Heart Association Task Force/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities [1] (DO NOT EDIT)
| Class III (Harm) |
| "1. CRT is not recommended for patients with NYHA class I or II symptoms and non-LBBB pattern with QRS duration less than 150 ms. (Level of Evidence: B) " |
| "2. CRT is not indicated for patients whose comorbidities and/or frailty limit survival with good functional capacity to less than 1 year. (Level of Evidence: C) " |
References
- ↑ "American College of Cardiology Foundation | Journal of the American College of Cardiology | 2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm AbnormalitiesA Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Retrieved 2012-09-11.